ASND
Ascendis Pharma A/SstockNASDAQ
Market OpenNov 16, 2026 10:36:50 AM EST
274.58USD-0.294%(-0.81)111,311
ASND Financials
In Q3 FY 2026 (ended ), Ascendis Pharma A/S (ASND) reported revenue of €369.66M, net income of €73.97M, operating cash flow of €188.79M, and assets of €2.43B in EUR (filed ).
Loading financial flows…